Literature DB >> 26183728

The mechanisms of action of St. John's wort: an update.

Mathias Schmidt1, Veronika Butterweck.   

Abstract

Pharmacological research confirms and supports the clinically observed antidepressant efficacy of St. John's wort (Hypericum perforatum L., SJW). This contribution is an update of a former review by the authors in 2007. Positive evidence of antidepressant effects has been found with SJW preparations, extract fractions, and single constituents. The efficacy of SJW is obviously defined by a range of parallel mechanisms of action, triggered by different constituents. In vitro research showed, among other tests, positive effects in neurotransmitter regulation (in beta adrenergic systems and glutamate receptors) and ion channel conductance. Antidepressant effects were confirmed in typical in vivo models such as the forced swimming test, the open field test, the tail suspension test, or a model of stress-impaired memory. The overall effect cannot be attributed to a single constituent or fraction. SJW is therefore an outstanding example of the total extract being defined as the active constituent of herbal medicines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183728     DOI: 10.1007/s10354-015-0372-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  37 in total

Review 1.  Neuropharmacology of St. John's Wort (Hypericum).

Authors:  D A Bennett; L Phun; J F Polk; S A Voglino; V Zlotnik; R B Raffa
Journal:  Ann Pharmacother       Date:  1998-11       Impact factor: 3.154

2.  Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.

Authors:  Murhaf Zaher; Ruoping Tang; Isabelle Bombarda; Faten Merhi; Brigitte Bauvois; Christian Billard
Journal:  Int J Oncol       Date:  2011-09-22       Impact factor: 5.650

Review 3.  St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature.

Authors:  J M Greeson; B Sanford; D A Monti
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

4.  The antidepressant hyperforin increases the phosphorylation of CREB and the expression of TrkB in a tissue-specific manner.

Authors:  Julien Gibon; Jean-Christophe Deloulme; Tiphaine Chevallier; Elodie Ladevèze; Djoher Nora Abrous; Alexandre Bouron
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-09       Impact factor: 5.176

Review 5.  The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.).

Authors:  P Nathan
Journal:  Mol Psychiatry       Date:  1999-07       Impact factor: 15.992

6.  The in vivo evaluation of anti-angiogenic effects of Hypericum essential oils using the chorioallantoic membrane assay.

Authors:  Hülya Tuba Kıyan; Betül Demirci; Kemal Hüsnü Can Başer; Fatih Demirci
Journal:  Pharm Biol       Date:  2013-09-18       Impact factor: 3.503

7.  Alleviation by Hypericum perforatum of the stress-induced impairment of spatial working memory in rats.

Authors:  Emil Trofimiuk; Jan J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

8.  Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.

Authors:  Lars Prenner; Anne Sieben; Karin Zeller; Dieter Weiser; Hanns Häberlein
Journal:  Biochemistry       Date:  2007-04-07       Impact factor: 3.162

Review 9.  Preclinical data supporting/refuting the use of Hypericum perforatum in the treatment of depression.

Authors:  Rosalia Crupi; Yousef Abdel Kareem Abusamra; Edoardo Spina; Gioacchino Calapai
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-06       Impact factor: 4.388

10.  Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system.

Authors:  O Grundmann; Y Lv; O Kelber; V Butterweck
Journal:  Neuropharmacology       Date:  2009-12-28       Impact factor: 5.250

View more
  10 in total

Review 1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

Authors:  Arun V Ravindran; Lynda G Balneaves; Guy Faulkner; Abigail Ortiz; Diane McIntosh; Rachel L Morehouse; Lakshmi Ravindran; Lakshmi N Yatham; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

2.  Hypericum perforatum extract modulates cortical plasticity in humans.

Authors:  Carmen Concerto; Hyunji Boo; Charles Hu; Priam Sandilya; Anita Krish; Eileen Chusid; Diego Coira; Eugenio Aguglia; Fortunato Battaglia
Journal:  Psychopharmacology (Berl)       Date:  2017-10-10       Impact factor: 4.530

3.  The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells.

Authors:  Francesca Felicia Caputi; Elio Acquas; Sanjay Kasture; Stefania Ruiu; Sanzio Candeletti; Patrizia Romualdi
Journal:  BMC Complement Altern Med       Date:  2018-01-10       Impact factor: 3.659

4.  St John's wort (Hypericum perforatum)-induced psychosis: a case report.

Authors:  Maria Ferrara; Francesco Mungai; Fabrizio Starace
Journal:  J Med Case Rep       Date:  2017-05-15

Review 5.  Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.

Authors:  Ghulam Murtaza; Naveed Ullah; Farah Mukhtar; Shamyla Nawazish; Saiqa Muneer
Journal:  Molecules       Date:  2017-10-21       Impact factor: 4.411

6.  No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-glycoprotein.

Authors:  Catherine Zahner; Esther Kruttschnitt; Julia Uricher; Michael Lissy; Martin Hirsch; Simon Nicolussi; Stephan Krähenbühl; Jürgen Drewe
Journal:  Clin Pharmacol Ther       Date:  2019-03-23       Impact factor: 6.875

Review 7.  Clinical relevance of St. John's wort drug interactions revisited.

Authors:  Simon Nicolussi; Jürgen Drewe; Veronika Butterweck; Henriette E Meyer Zu Schwabedissen
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

8.  Mania Associated With Herbal Medicines, Other Than Cannabis: A Systematic Review and Quality Assessment of Case Reports.

Authors:  Emmanuelle Bostock; Kenneth Kirkby; Michael Garry; Bruce Taylor; Jason A Hawrelak
Journal:  Front Psychiatry       Date:  2018-07-06       Impact factor: 4.157

Review 9.  Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies.

Authors:  Michela Novelli; Pellegrino Masiello; Pascale Beffy; Marta Menegazzi
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

Review 10.  The Role of Cyclodextrins in the Design and Development of Triterpene-Based Therapeutic Agents.

Authors:  Alexandra Prodea; Alexandra Mioc; Christian Banciu; Cristina Trandafirescu; Andreea Milan; Roxana Racoviceanu; Roxana Ghiulai; Marius Mioc; Codruta Soica
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.